sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Syphilis Testing Market by Types (Primary Syphilis, Secondary Syphilis) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

Syphilis Testing Market by Types (Primary Syphilis, Secondary Syphilis) -...

Home / Categories / Healthcare
Syphilis Testing Market by Types (Primary Syphilis, Secondary Syphilis) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020
Syphilis Testing Market by Types...
Report Code
RO1/113/1006

Publish Date
01/May/2015

Pages
118
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.1 Research methodology
1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Upcoming trends for Syphilis diagnostic testing market
3.2.1 Executing and ensuring accreditation for the qualification of participants in National Screening Programs around the globe.
3.2.2 Technological Advancements for Syphilis diagnostic testing market
3.3 Syphilis diagnostic tests
3.4 Key Findings
3.4.1 Top Factors Impacting global Syphilis diagnostic testing market
3.4.2 Top Investment Pockets of global Syphilis diagnostic testing market (2014-2020)
3.4.3 Top winning strategies of global Syphilis diagnostic testing market
3.5 Government Regulations and reimbursement scenario
3.5.1 Government Regulation
3.5.2 Reimbursement policies for Syphilis testing
3.6 Value Chain Analysis
3.6.1 Primary Activities
3.6.2 Supportive Activities
3.7 Market dynamics
3.7.1 Drivers
3.7.1.1 Growing incidence rates and increasing prevalence rates of Syphilis
3.7.1.2 Implementation of National Screening Programs
3.7.1.3 Supporting Reimbursement for Syphilis testing
3.7.2 Restraints
3.7.2.1 Social stigma associated with patients visiting specialized STD clinics.
3.7.2.2 Huge proportion of patients infected with Syphilis in remote areas.
3.7.2.3 Stringent regulatory abidance requirements for the participants of Syphilis market
3.7.3 Opportunities
3.7.3.1 Decreasing number of visits to GUM clinics and specialized STD clinics
3.7.3.2 National screening Programs across the globe
3.7.3.3 Niche opportunities for technology and POC test providers in an emerging economies

Chapter: 4 GLOBAL SYPHILIS TESTING MARKET, BY TYPE, 2014-2020
4.1 P&S Syphilis testing (volume and value)
4.1.1 Key market trends
4.1.2 Market size and forecast, (volume & value)
4.1.2.1 Global Testing Market for Syphilis,value, ($million)
4.1.2.2 Global Testing Market for Syphilis, volume, (million)
4.2 Primary Syphilis
4.3 Secondary Syphilis
4.3.1 Market size and forecast, (volume & value)

Chapter: 5 GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020
5.1 North America
5.1.1 Market size and forecast, (volume & value)
5.1.2 U.S.
5.1.2.1 Market size and forecast (Volume & Value)
5.1.3 Mexico
5.1.3.1 Market size and forecast, (volume & value)
5.1.4 Canada
5.1.4.1 Market size and forecast, (volume & value)
5.2 Europe
5.2.1 Market size and forecast, (volume & value)
5.2.2 Spain
5.2.2.1 Market size and forecast, (volume & value)
5.2.3 Greece
5.2.3.1 Market size and forecast, (volume & value)
5.2.4 Belgium
5.2.4.1 Market size and forecast, (volume & value)
5.2.5 Germany
5.2.5.1 Market size and forecast, (volume & value)
5.2.6 Moldova
5.2.6.1 Market size and forecast, (volume & value)
5.2.7 United Kingdom
5.2.7.1 Market size and forecast, (volume & value)
5.2.8 Rest of Europe
5.2.8.1 Market size and forecast, (volume & value)
5.3 Asia Pacific
5.3.1 Market size and forecast, (volume & value)
5.3.2 India
5.3.2.1 Market size and forecast, (volume & value)
5.3.3 China
5.3.3.1 Market size and forecast, (volume & value)
5.3.4 Japan
5.3.4.1 Market size and forecast, (volume & value)
5.3.5 Australia
5.3.5.1 Market size and forecast, (volume & value)
5.3.6 Rest of Asia-Pacific
5.3.6.1 Market size and forecast, (volume & value)
5.4 LAMEA
5.4.1 Market size and forecast, (volume & value)
5.4.2 Latin America
5.4.2.1 Market size and forecast, (volume & value)
5.4.2.2 Argentina
5.4.2.2.1 MARKET SIZE AND FORECAST, (VOLUME & VALUE)
5.4.3 Middle East
5.4.3.1 Market size and forecast, (volume & value)
5.4.4 Africa
5.4.4.1 Market size and forecast, (volume & value)

Chapter: 6 COMPANY PROFILES
6.1 Roche Diagnostics
6.1.1 Company overview
6.1.2 Roche Diagnostics company snapshot
6.1.3 Operating business segments
6.1.4 Financial performance
6.1.5 Strategic moves and developments
6.1.6 SWOT analysis Roche Diagnostics
6.2 BioMerieux
6.2.1 Company overview
6.2.2 Biomerieux Company Snapshot
6.2.3 Operating business segments
6.2.4 Business performance
6.2.5 SWOT analysis of BioMerieux
6.3 Hologic, Inc.
6.3.1 Company overview
6.3.2 Hologic, Inc. Company Snapshot
6.3.3 Operating business segments
6.3.4 Financial performance
6.3.5 Strategic moves and developments
6.3.6 SWOT analysis of Hologic Inc
6.4 Becton Dickinson And Company
6.4.1 Company overview
6.4.2 Becton Dickinson And Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business performance
6.4.5 Key Strategies and development
6.4.6 SWOT analysis of Becton Dickinson and Company
6.5 Cepheid Inc.
6.5.1 Company overview
6.5.2 Cephide Inc. company snapshot
6.5.3 Operating Business Segments
6.5.4 Financial performance
6.5.5 Strategic moves and developments
6.5.6 SWOT analysis of Cepheid Inc.
6.6 Danaher Corporation
6.6.1 Company overview
6.6.2 Danaher Corporation Company Snapshot
6.6.3 Operating business segments
6.6.4 Business performance
6.6.5 Key Strategies and development
6.6.6 SWOT analysis of Danaher Corporation
6.7 Affymetrix, Inc.
6.7.1 Company overview
6.7.2 Affymetrix Inc. Company Snapshot
6.7.3 Operating. business segments
6.7.4 Financial performance
6.7.5 SWOT analysis of Affymetrix Inc
6.8 Alere Inc.
6.8.1 Company overview
6.8.2 Alere Inc. Company Snapshot
6.8.3 Operating business segments
6.8.4 Business performance
6.8.5 Key Strategies and developments
6.8.6 SWOT analysis of Alere Inc.
6.9 Abbott Laboratories
6.9.1 Company overview
6.9.2 Abbott Laboratories company snapshot
6.9.3 Operating business segments
6.9.4 Financial performance
6.9.5 Strategic moves and developments
6.9.6 SWOT analysis of Abbott Laboratories
6.10 DiaSorin
6.10.1 Company overview
6.10.2 DiaSorin Company Snapshot
6.10.3 Operating business segments
6.10.4 Financial performance
6.10.5 Strategic moves and developments
6.10.6 SWOT analysis of DiaSorin

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com